Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation

Amiodarone is a frequently used antiarrhythmic drug in patients with end-stage heart failure. Given its long half-life, pre-transplant use of amiodarone has been controversially discussed, with divergent results regarding morbidity and mortality after heart transplantation (HTX).Aim: The aim of thi...

Full description

Bibliographic Details

Main Authors:	Rivinius, Rasmus (Author) , Helmschrott, Matthias (Author) , Ruhparwar, Arjang (Author) , Schmack, Bastian (Author) , Erbel, Christian (Author) , Gleißner, Christian A. (Author) , Akhavanpoor, Mohammadreza (Author) , Frankenstein, Lutz (Author) , Darche, Fabrice Fernand (Author) , Schweizer, Patrick Alexander (Author) , Thomas, Dierk (Author) , Ehlermann, Philipp (Author) , Bruckner, Thomas (Author) , Katus, Hugo (Author) , Dösch, Andreas (Author)
Format:	Article (Journal)
Language:	English
Published:	16 February 2016
In:	Drug design, development and therapy Year: 2016, Volume: 10, Pages: 677-686
ISSN:	1177-8881
DOI:	10.2147/DDDT.S96126
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2147/DDDT.S96126 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/long-term-use-of-amiodarone-before-heart-transplantation-significantly-peer-reviewed-article-DDDT
Author Notes:	Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Bastian Schmack, Christian Erbel, Christian A. Gleissner, Mohammadreza Akhavanpoor, Lutz Frankenstein, Fabrice F. Darche, Patrick A. Schweizer, Dierk Thomas, Philipp Ehlermann, Thomas Bruckner, Hugo A. Katus, Andreas O. Doesch